{"filing":{"accession_number":"0001171843-26-004094","cik":"0001626971","ticker":"CRVS","company_name":"Corvus Pharmaceuticals, Inc.","form":"8-K","filing_date":"2026-06-12","report_date":null,"primary_document":"f8k_061226.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1626971/000117184326004094/f8k_061226.htm"},"events":[{"id":10776,"run_id":9454,"accession_number":"0001171843-26-004094","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This 8-K Item 5.07 discloses the results of Corvus Pharmaceuticals' 2026 Annual Meeting of Stockholders held on June 11, 2026, including tabulated votes on three proposals: election of Class I directors (Richard A. Miller, M.D. and Linda S. Grais, M.D., J.D.), ratification of PricewaterhouseCoopers LLP as independent auditor, and a non-binding advisory vote on named executive officer compensation. The disclosure provides vote counts (For, Against, Abstain, Broker Non-Votes) for each proposal, which is the standard format for shareholder vote results required under Item 5.07.","company_name":"Corvus Pharmaceuticals, Inc.","ticker":"CRVS","filing_date":"2026-06-12","form":"8-K","submitted_at":null,"items":[{"id":7173,"accession_number":"0001171843-26-004094","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This 8-K Item 5.07 discloses the results of Corvus Pharmaceuticals' 2026 Annual Meeting of Stockholders held on June 11, 2026, including tabulated votes on three proposals: election of Class I directors (Richard A. Miller, M.D. and Linda S. Grais, M.D., J.D.), ratification of PricewaterhouseCoopers LLP as independent auditor, and a non-binding advisory vote on named executive officer compensation. The disclosure provides vote counts (For, Against, Abstain, Broker Non-Votes) for each proposal, which is the standard format for shareholder vote results required under Item 5.07.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-13T02:16:58.920312+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":7173,"accession_number":"0001171843-26-004094","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This 8-K Item 5.07 discloses the results of Corvus Pharmaceuticals' 2026 Annual Meeting of Stockholders held on June 11, 2026, including tabulated votes on three proposals: election of Class I directors (Richard A. Miller, M.D. and Linda S. Grais, M.D., J.D.), ratification of PricewaterhouseCoopers LLP as independent auditor, and a non-binding advisory vote on named executive officer compensation. The disclosure provides vote counts (For, Against, Abstain, Broker Non-Votes) for each proposal, which is the standard format for shareholder vote results required under Item 5.07.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-13T02:16:58.920312+00:00","company_name":"Corvus Pharmaceuticals, Inc.","ticker":"CRVS","filing_date":"2026-06-12"}]}